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Chaperones are abundant cellular proteins that
promote the folding and function of their substrate
proteins (clients). In vivo, chaperones also associate
with a large and diverse set of cofactors (cochaper-
ones) that regulate their specificity and function.
However, how these cochaperones regulate protein
folding and whether they have chaperone-indepen-
dent biological functions is largely unknown. We
combined mass spectrometry and quantitative
high-throughput LUMIER assays to systematically
characterize the chaperone-cochaperone-client
interaction network in human cells. We uncover
hundreds of chaperone clients, delineate their partic-
ipation in specific cochaperone complexes, and
establish a surprisingly distinct network of protein-
protein interactions for cochaperones. As a salient
example of the power of such analysis, we establish
that NUDC family cochaperones specifically asso-
ciate with structurally related but evolutionarily
distinct b-propeller folds. We provide a framework
for deciphering the proteostasis network and its
regulation in development and disease and expand
the use of chaperones as sensors for drug-target
engagement.INTRODUCTION
Perturbation of the proteostasis network has been implicated in
many diseases ranging from neurodegeneration to cancer and
Mendelian disorders (Powers et al., 2009). At the same time,
preclinical models and clinical results obtained with drugs434 Cell 158, 434–448, July 17, 2014 ª2014 Elsevier Inc.that target central modules of the network, such as proteasome
and Hsp90 inhibitors, have shown that targeting this network
has high therapeutic potential (Trepel et al., 2010). It is clear,
however, that we need a more detailed understanding of
the proteostasis network to decipher exactly how it is per-
turbed in disease and to develop more effective and specific
therapeutics.
Chaperones are the most prominent class of proteins that
shape this network. They transiently bind thousands of sub-
strate proteins (clients) and promote their folding, trafficking,
and degradation (Saibil, 2013). Systematic proteomic ap-
proaches have started to uncover the client protein ensembles
of chaperones (Calloni et al., 2012; Yam et al., 2008; Zhao
et al., 2005). However, previous studies employed widely vary-
ing methods and model organisms, which makes it challenging
to quantitatively compare results and integrate them into a
coherent model. Perhaps more importantly, however, chaper-
ones do not function in isolation. Rather, they dynamically
associate with a diverse set of cofactors, or cochaperones. Co-
chaperones provide a host of auxiliary functions to chaperones,
ranging from regulating the rate of client release to recruiting
specific clients to the core chaperone (Echtenkamp and
Freeman, 2012). A growing body of evidence suggests that co-
chaperones play much more than a supportive role. Some ‘‘co-
chaperones’’ possess intrinsic chaperone activity themselves
(Freeman et al., 1996) and others independently regulate
cellular processes that are distinct from those of the canonical
chaperones (Echtenkamp et al., 2011). Yet, both the client-pro-
tein specificity and possible chaperone-independent functions
of most cochaperones remain enigmatic.
Here, we use a systematic and integrative approach to survey
the physical interaction landscape of all knownHsp90 cochaper-
ones and several known Hsp70 cochaperones. We combine
mass spectrometry (MS) and quantitative LUMIER assays to
characterize the client specificity of cochaperones and begin
to decipher the proteostasis network as a whole.
AB
Figure 1. Two-Pronged Approach for Char-
acterizing the Proteostasis Network in
Human Cells
(A) Sixty-eight chaperones, cochaperones, or
quality-control factors tagged with either 3xFLAG
tag or Renilla luciferase were stably expressed in
293T cells. Interactors were identified by either
AP-MS (3xFLAG tagged proteins) or LUMIER
assay (Renilla-tagged proteins).
(B) Chaperones, cochaperones, protein quality-
control factors, and other proteins characterized in
this study.
See also Figure S1.RESULTS
To systematically characterize the cytoplasmic proteostasis
network in human cells, we generated two sets of stable
293T cell lines. One set consisted of 54 proteins tagged with
a 3xFLAG-V5 epitope for affinity purification coupled to MS
(AP-MS), and the other consisted of 60 proteins fused to Re-
nilla luciferase for a quantitative LUMIER assay (Taipale
et al., 2012; Figure 1A). Importantly, almost all surveyed pro-
teins were tagged in the C terminus. This ensured that the
interactions represent steady-state, posttranslational chap-
erone-client interactions rather than transient cotranslational
interactions (as nascent chains cannot be captured with a
C-terminal tag).
We selected proteins for our analysis based onmultiple criteria
(Figure 1B). First, we cloned all previously identified and charac-
terized Hsp90 cochaperones and Hsp70 nucleotide-exchange
factors. Second, we cloned a group of proteins with either a
tetratricopeptide repeat (TPR) domain or a CS (CHORD and
Sgt1) domain, as most Hsp90 cochaperones contain one or
more of these domains (Taipale et al., 2010). Third, we selected
several other proteostasis regulators, including four subunits of
the 19S proteasome regulatory particle, two subunits of the pre-
foldin complex, and six HSF family transcription factors. Finally,
during the course of the project we identified eight prominent
cochaperone interactors, which were cloned for systematic
analysis (Figure 1B).Cell 158, 434–Unbiased Discovery of Chaperone-
Cochaperone-Client Interactions
by AP-MS
Cochaperones were affinity purified from
cell lysates with anti-FLAG beads and
interacting proteins identified by MS.
To distinguish significant interactors
from background noise, we used the
SAINTexpress algorithm (Teo et al.,
2014). To validate the AP-MS interactions
with an orthogonal method, we used the
LUMIER assay. In this assay, a prey pro-
tein fused to Renilla luciferase is stably
expressed in 293T cells. Putative interac-
tors (baits) are tagged with a 3xFLAG
epitope and transfected into the reporter
cell line. Cells lysates are then incubated
on 384-well plates coated with an anti-FLAG antibody, leading
to capture of the bait protein. Interaction of the bait protein
with the tested chaperone can then be quantified as lumines-
cence (Barrios-Rodiles et al., 2005). As a cutoff for high-
confidence interactions, we used a LUMIER scoreR 7 (with an
estimated upper bound for false-discovery rate [FDR] of 4.4%).
To characterize the validation rate of AP-MS interactions, we
cloned 423 interacting proteins that scored SAINT AvgP R 0.5
in any one of the AP-MS experiments. We tested these proteins
for interaction with all 54 baits using LUMIER. Using a stringent
cutoff for SAINT (AvgPR 0.85; estimated FDR of 1.8%), 28% of
interactions identified in AP-MS were validated by LUMIER, and
81% of them were novel (Figures S1A and S1B available online;
Table S1). Conversely, 35% of interactions that scored positive
in LUMIER had an AvgP scoreR 0.85 (Figure S1C). These valida-
tion rates are consistent with the observation that any one pro-
tein-protein interaction assay can detect about one-third of all
interactionswithout compromising specificity (Braunet al., 2009).
Both the validation rate and the overlapwith published interac-
tions decreased with lower scores, supporting our selection of
a stringent cutoff (Figures S1A–S1C). We also validated that
SAINTexpress was the best computational algorithm for identi-
fying high-confidence interactors in our data set (Figure S1E).
Finally, to investigate whether the location of the epitope tag
affected the interactions identified, we assayed several proteins
again with a tag in the other terminus. The results were highly
similar (Figures S2A–S2C).448, July 17, 2014 ª2014 Elsevier Inc. 435
Figure 2. The Proteostasis Network in Human Cells Characterized by MS
Protein-protein interactions were identified by AP-MS and filtered using the SAINTexpress algorithm with cutoff AvgPR 0.85. Proteins are shown as rectangles,
and lines represent interactions between the proteins. Bait proteins are indicated by dark edges. The width of the edges corresponds to the number of spectral
counts identified for each interaction. Examples of biologically coherent interactions are indicated in colors. See also Figures S1 and S2 and Table S1.Global Features of the AP-MS Interaction Network:
Chaperone Complexes
We identified 486 high-confidence interactions for the 54 tagged
baits by AP-MS. The number of identified interactions did not
correlate with bait protein expression level, suggesting that no
systematic biases were introduced by exogenous expression
(Figure S1E). Notably, our chaperone-focused AP-MS network
wasmuch larger andmore interconnected than chaperone inter-
action networks that could be recovered from previous large-
scale studies (Figures S1F, S2D, and S2E).
The AP-MS network revealed two tiers of organization. The
first tier connected all but six bait proteins into a central network
with multiple edges between chaperones and their clients
(Figure 2). Two subnetworks emerged within this central
network, corresponding to known Hsp90 and Hsp70 chaperone
complexes (Figure 2, blue and orange squares, respectively).
These two subnetworks were bridged by a unique set of cocha-
perones (Figure 2, tan squares). Among these were the well-
known bridging factors HOP/STIP1, TPR2/DNAJC7, and CHIP/436 Cell 158, 434–448, July 17, 2014 ª2014 Elsevier Inc.STUB1, validating our approach (Brychzy et al., 2003; Schmid
et al., 2012; Xu et al., 2002). Other bridging factors in this
first tier of organization included members of the Hsp40 chap-
erone family (DNAJB1 and DNAJB6), HSP70-binding protein 1
(HSPBP1), the TPR domain protein EDRF1, and the E3 ligase
NRDP1/RNF41.
Local Features of the AP-MS Interaction Network:
Unique Chaperone-Client Interactions
The second tier of organization consisted of cochaperone-client
interactions. For example, we identified several protein kinases
that copurified with CDC37, a known kinase-specific Hsp90 co-
chaperone (Taipale et al., 2012). CDC37L1/Harc, a protein that
is 62% similar to CDC37 (Figure S3A; Scholz et al., 2001), simi-
larly interacted very strongly with Hsp90 and several of its co-
chaperones (Figures 2 and 3B). Otherwise, however, the inter-
actions of these cochaperones were unique. For example,
CDC37L1 interacted with the bridging factor HOP, whereas
CDC37 copurified with AHA1 (Figure 3B), but even more
strikingly, CDC37L1 did not associate with any kinases in AP-
MS (Figures 2 and 3B). CDC37L1 lacks the very N terminus of
CDC37, which is required for kinase interaction and the cellular
function of CDC37 (Shao et al., 2003), and is able to mediate
strong interaction with ARAF when fused to CDC37L1 (Fig-
ure S3B). Thus, our findings establish that CDC37L1 has
evolved a unique position in the Hsp90 chaperone machinery,
and that due to its divergent N terminus, CDC37L1 does not
associate with kinase clients.
Unique Associations of FKBP Family Cochaperones
ManyHsp90 cochaperones aremembers ofmultiprotein families
and share significant homology with each other. One of the most
prominent of these cochaperone groups is the FK506-binding
protein family, or FKBPs. These proteins share an FK506-binding
domain and one or more TPR domains, which confer interaction
with Hsp90 (Figure 3A). Our AP-MS data set robustly detected
shared interactions between these cochaperones and several
members of the Hsp90 chaperone machinery (Figure 3B), but it
also revealed distinct associations for each.
FKBP51 (aka FKBP5), but none of the other FKBPs, associ-
ated with four distinct protein families, pointing to an unexpect-
edly diverse repertoire of clients. First, FKBP51 interacted with a
subset of the kinases that interacted with CDC37 (Figure 3B).
Second, FKBP51 interacted with the Argonaute proteins AGO1
and AGO2, which are known Hsp90 clients involved in small
RNA biogenesis (Iwasaki et al., 2010). Third, FKBP51 associated
with three transcription factors (EGLN1, PDCD2, ANKMY2), all of
which contain an MYND zinc finger domain, suggesting that this
domain represents an Hsp90-interacting protein fold.
Perhaps most surprisingly, we found that FKBP51 interacted
with MCM4 and MCMBP (Figure 3B), two subunits of the MCM
complex that are involved in DNA replication initiation and fork
progression. FKBP51 purification recovered the most peptides
for one particular subunit of the complex, MCMBP (Jagannathan
et al., 2012). We validated this interaction by AP of 3xFLAG-
tagged MCMBP. Indeed, MCMBP interacted with all members
of the MCM complex and with FKBP51 (Figure S3C). Hsp90,
however, was not enriched in the MCMBP purifications, and
we did not detect an interaction between Hsp90 and MCMBP
by LUMIER assay or by coimmunoprecipitation (Figures S3D
and S3E), suggesting that FKBP51 associates with MCMBP
independently of Hsp90. Thus, our results reveal an unexpected
Hsp90-independent link between FKBP51 and genome mainte-
nance. Corroborating our results, a recent systematic small
interfering RNA (siRNA) screen identified FKBP51 as a factor in
modulating the cellular response to DNA damage (Cotta-Ramu-
sino et al., 2011).
Although their interactomes were significantly more compact
than that of FKBP51, all of the other FKBPs also exhibited unique
interactions with other proteins (Figure 3B). For example, the
FKBP38 (aka FKBP8) interactome suggested a link to G protein
signaling through interaction with PDCL, which acts as a chap-
erone for G protein g subunits (Lukov et al., 2006; Figure 3B).
In contrast, the highly homologous cochaperone FKBP36 (aka
FKBP6) did not interact with PDCL, but instead associated
with the oxysterol-binding protein OSBP (Burgett et al., 2011;
Figure 3B).FKBP36 as a Sensor for Drug-Target Interactions
We recently reported that Hsp90 and Hsp70 can be used as
sensors for drug-target interactions in living cells (Taipale
et al., 2013) because they are exquisitely sensitive to the
conformational status of the client protein. Binding of a small
molecule conformationally stabilizes the protein it targets,
decreasing the association of the target with chaperones.
Recently, a class of natural products (ORPphilins) with potent
activity against cancer cell lines was shown to target OSBP
(Burgett et al., 2011). Discovering the OSBP-FKBP36 interac-
tion by AP-MS gave us an opportunity to investigate the gen-
eral applicability of the chaperone assay for new types of
drug-target interactions.
We therefore asked whether the ORPphilin OSW-1 would
disrupt the interaction between FKBP36 and OSBP, as
measured by LUMIER. Indeed, OSW-1 treatment led to the
dissociation of OSBP from FKBP36 (Figure 3C). The potency of
OSW-1 in disrupting the interaction was 60 nM (EC50), which is
very close to the Ki of the compound (26 nM; Burgett et al.,
2011). Next, we tested four structural analogs of OSW-1. Two
of them (compounds 6 and 7) are active in cellular assays,
whereas compounds 9 and 10 are inactive (Figure S3F; Burgett
et al., 2011). Consistent with their different cellular effects,
compounds 9 and 10 did not disrupt the OSBP-FKBP36 interac-
tion, whereas compounds 6 and 7 did (Figure 3C). Thus, the bio-
logical activity of the OSW-1 family compounds is reflected in
their ability to disrupt the interaction between OSBP and
FKBP36. Disruption of the interaction could be caused either
by overlapping binding sites for FKBP36 and OSW-1 or by ther-
modynamic stabilization of theOSBP fold. In any case, the use of
chaperones and cochaperones as sensors of drug-target inter-
actions is likely to be very broadly applicable.
Unique Associations of BAG Family Cochaperones
BAG proteins comprise a family of homologous cochaperones
for Hsp70. All of these proteins regulate Hsp70’s ATPase activity,
interacting with Hsp70 through a conserved BAG domain in their
C termini (Figure 3D; Kampinga and Craig, 2010). Little is known,
however, about their biological functions and whether they
contribute to Hsp70 client specificity. Again, our AP-MS results
pointed to unique biological connections for at least four of the
five family members (Figure 3E).
BAG1 interacted with the E3 ubiquitin ligase Listerin (LTN1),
which is involved in ribosomal quality control (RQC) of stalled
polypeptides (Bengtson and Joazeiro, 2010). As BAG1 is known
to regulate the degradation of at least some Hsp70 and Hsp90
clients (Tsukahara and Maru, 2010), our results suggest it may
be also involved in the degradation of proteins targeted by
RQC. As previously reported (Fuchs et al., 2010), BAG3 associ-
ated with the small heat shock proteins Hsp22/HSPB8 and
Hsp27/HSPB1. In addition, we detected a robust interaction
with HSF1, the master regulator of the heat-shock response
(Figure 3E).
BAG5 and BAG4 interacted with protein complexes that have
not previously been associated with chaperones. BAG5 purifica-
tion revealed the spindle checkpoint components Mad1/
MAD1L1 and Mad2/MAD2L1 as the most prominent interactors
(Schuyler et al., 2012). BAG4, in contrast, interacted with threeCell 158, 434–448, July 17, 2014 ª2014 Elsevier Inc. 437
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central components of the mRNA decapping complex: DCP1A,
EDC3, and DDX6 (Figure 3E). These three proteins localize to
cytoplasmic structures known as processing bodies, or P
bodies, which are involved in mRNA decapping, degradation,
and translational silencing (Eulalio et al., 2007).
To test whether BAG4 also localizes to P bodies, we trans-
fected HeLa cells with EYFP-BAG4. When EYFP-BAG4 was
expressed at low levels, it colocalized with endogenous
DCP1A in cytoplasmic foci (Figure 3F). Because overexpression
of P body components often modulates P body formation (Eula-
lio et al., 2007), we also examined cells in which BAG4 was ex-
pressed at high levels. In such cells, EYFP-BAG4 was localized
more diffusely in the cytoplasm and DCP1A localization also
became diffuse (Figure 3F, lower panel). Thus, BAG4 overex-
pression disrupted P body organization. We then investigated
whether this effect was dependent on the association of BAG4
with Hsp70. We introduced a point mutation in the BAG domain
of BAG4 (D424A) that disrupts its association with Hsp70 (Bri-
knarova´ et al., 2002; Figure S3G). However, mutant BAG4 still
localized to P bodies and disrupted P body organization at
high expression levels (Figure S3H). Our data thus establish
BAG4 as a component of P bodies and suggest that this function
is independent of Hsp70.
Quantitative Profiling of the Human Chaperone-
Client Landscape
The network we uncovered by AP-MS was surprisingly compact
and likely represented only the most abundant chaperone-client
interactions. To further expand the network and to investigate
more quantitatively how client proteins are integrated within it,
we systematically surveyed pairwise interactions between
clients and cochaperones with LUMIER. To this end, we con-
structed a panel of 800 query proteins (Table S1). This set
included known Hsp90 clients (http://www.picard.ch), a subset
of kinases, E3 ligases and transcription factors that we previously
identified as Hsp90 clients (Taipale et al., 2012), and the 423 pro-
teins that we used to characterize the overlap betweenAP-MS in-
teractorsandLUMIERassay (seeabove).Afterwefilteredoutpro-
teins that were not expressed at detectable levels, our data set
comprised 40,604 pairwise assays, each performed in duplicate.
We first examined the effects of theHsp90 inhibitor ganetespib
on Hsp90 and Hsp70 interactions (Ying et al., 2012). This served
two purposes. First, Hsp90 inhibition leads to dissociation of
most known clients from Hsp90 (Taipale et al., 2012). Although
dissociation does not directly prove that the interactor is a client,Figure 3. Unique Associations of FKBP and BAG Family Cochaperone
(A) The FKBP (FK506-binding protein) family of Hsp90 cochaperones is characte
domain.
(B) Interaction network of FKBP family cochaperones. Selected unique interactio
(C) The natural compound OSW-1 disrupts the interaction between OSBP and FKB
FKBP36-Renilla luciferase fusion. One hour before cell lysis, cells were treated wi
and FKBP36 was then measured with LUMIER. Error bars indicate SD.
(D) BAG proteins are a family of homologous Hsp70 cofactors that interact with
(E) Interaction network of BAG family cochaperones. Selected unique interaction
(F) BAG4 colocalizes with the P body component DCP1A and regulates P body a
were then fixed and stained for endogenous DCP1A (red), a component of P bod
YFP-BAG4 is expressed at high levels, endogenous DCP1A appears diffuse.
See also Figure S3.it provides supportive evidence. Second, this allowed us to test
the generality of client handoff from Hsp70 to Hsp90. Previous
studies have shown that Hsp90 inhibition is accompanied by
accumulation of clients with the upstream chaperone Hsp70
(Xu et al., 2002). Our platform enabled us systematically test
this model. To this end, cells expressing Renilla tagged Hsp90b
or Hsc70 were transfected with the bait protein collection and
treated with 1 mM ganetespib for 1 hr before LUMIER assay.
Ganetespib treatment had a strong effect on most Hsp90-
client interactions. Of the 630 unique proteins that we detected
by LUMIER assay, 46% significantly decreased their interaction
with Hsp90b (change in LUMIER score > 1.5, adjusted p value <
0.05; Figure 4A). Using a binary cutoff for Hsp90b interactions
(LUMIER score R 7), 81% of high-confidence interactors (84/
104) decreased their interaction with the chaperone (Table S1).
Notably, one-third (7/20) of those that still interacted with
Hsp90b were known cochaperones (Figure 4A; Table S1). Yet,
even some cochaperones lost their interaction with Hsp90.
This is consistent with the observation that Hsp90 inhibitors
stabilize a specific conformation of the chaperone, leading to
differential cochaperone interactions (Gano and Simon, 2010).
The effect of ganetespib on Hsc70 interactions was more subtle
but still clearly detectable: 16% of the tested proteins increased
their interaction with Hsc70 upon ganetespib treatment. This
was particularly noticeable for proteins that interacted strongly
with Hsc70 (Figure 4B). None of the tested Hsp70 cochaperones
were affected by inhibitor treatment (Figure 4B).
We then compared the effects of ganetespib on Hsp90b and
Hsc70 interactions (Figure 4C). Most proteins that decreased
their association with Hsp90b did not significantly change their
interaction with Hsc70. Those that did, however, generally asso-
ciated more strongly with Hsc70 (red circles, Figure 4C). This
group of proteins was enriched in kinases (p < 0.0001, Fisher’s
exact test; Table S1). A few, mostly cochaperones, decreased
their interaction with both Hsp90b and Hsc70 (blue circles, Fig-
ure 4C). Interestingly, five proteins increased their interaction
with both Hsp90 and Hsp70 after drug treatment (orange circles,
Figure 4C). Theymight represent clients that are chaperoned in a
distinct manner.
Taken together, these experiments demonstrate that Hsp90
inhibition leads to an almost global loss of Hsp90-client interac-
tions. This is accompanied by a more subtle increase in Hsp70
interaction for many clients, in particular kinases. The results
also suggest that the vast majority of these interactions are
true chaperone-client interactions.s
rized by one or more TPR domains that can interact with Hsp90 and the FKBP
n partners and protein classes are indicated.
P36. 3xFLAG-taggedOSBPwas transfected into 293T cells stably expressing
th a dilution series of the indicated compounds. The interaction between OSBP
Hsp70 through their BAG domain.
partners are indicated.
ssembly. Top panel: YFP-BAG4 (green) was transfected into HeLa cells, which
ies. DNA was stained with Hoechst 33342 (cyan). Bottom panel: in cells where
Cell 158, 434–448, July 17, 2014 ª2014 Elsevier Inc. 439
CA B Figure 4. Effect of Transient Hsp90 Inhibi-
tion on Chaperone Interactions
(A) Hsp90 inhibition leads to dissociation of most
clients from Hsp90b. Hsp90b was surveyed for
interaction with 800 proteins by LUMIER assay.
Cells were treated for 1 hr with 1 mM ganetespib or
left untreated before the assay. Hsp90 cochaper-
ones are shown as green circles. Interaction
strength was quantitated as LUMIER scores.
(B) Hsp90 inhibition leads to stronger association
of some proteins with Hsc70. Hsc70 was assayed
for interaction with 800 proteins as in (A). Hsp70
cochaperones are shown as green circles.
(C) Comparison of the effects of ganetespib on
Hsp90b and Hsc70 interactions. The plot shows the change in interaction of 800 tested proteins with Hsp90b and Hsc70 (change is defined as LUMIER score
drug – LUMIER score control). Proteins that show differential association with both chaperones are indicated in orange (both increase), blue (both decrease), or
red (decrease in Hsp90b interaction, increase in Hsc70 interaction). Selected proteins are labeled.
See also Table S1.Unbiased Clustering of Proteostasis Regulators by
Protein Interaction Profiles
The application of quantitative analyses has often revealed unex-
pected associations between genes in gene-expression and
genetic-interaction profiles (Eisen et al., 1998; Tong et al.,
2004). The quantitative readout of our assay allowed us to exploit
this approach for the analysis of protein-protein interactions.
That is, rather than employing statistical cutoffs to determine
significant interactions, we used the entire data set and treated
interaction scores as quantitative variables. Although LUMIER
scores do not directly correspond to biophysical parameters
such as affinity or stoichiometry, correlations in the interaction
profiles can reveal novel relationships between proteins.
We first clustered chaperones and cochaperones based on
their similarities in client-interaction profiles. This recovered
well-known biological complexes (Figure 5A). For example,
Hsp70 and Hsp90 machineries formed distinct clusters: Hsp70
clustered together with Hsc70, their nucleotide-exchange factor
BAG2, and the E3 ligase CHIP (Figure 5A, orange cluster),
whereasHsp90 andmanyof its cochaperones formed a separate
group (Figure 5A, blue cluster). Similarly, three components of the
proteasome regulatory particle (PSMD4, PSMC1, and ADRM1)
clustered together, as did the two subunits of the prefoldin com-
plex, PFDN2 and PFDN5 (Figure 5A). Notably, some of the clus-
ters formed by LUMIER interactions were different from those
recovered in AP-MS. RPAP3 interacted strongly with the Hsp90
machinery in AP-MS, but its interaction profile in LUMIER con-
nected it more tightly with prefoldin subunits. The most likely
explanation for this is that chaperone complexes in AP-MS are
mainly connected by interactions between complex members,
whereas LUMIER clusters tend to be determined by shared inter-
actions of cluster members. The recovery of well-established,
biologically coherent chaperone clusters interacting with a diver-
sity of known substrate proteins validates our approach.
Paralogous Chaperones Have Very Similar Client and
Cochaperone Interactions
We first examined the interaction profiles of the Hsp90 and
Hsp70 family chaperones. As expected, cochaperones showed
distinct specificities for Hsp90 (Figure 5B, red circles) or Hsp70
(Figure 5B, ochre circles). However, most clients interacted440 Cell 158, 434–448, July 17, 2014 ª2014 Elsevier Inc.with both Hsp90b and Hsc70 to a similar degree (Figure 5B, light
blue circles). Consequently, the interaction profiles of the
chaperones were themselves correlated (R2 = 0.34). Yet, some
clients clearly preferred one chaperone over the other. Hsp90b
interacted particularly strongly with kinases (Figure 5B, filled
blue circles), whereas the transcription factors p53 and HSF1
were among the most Hsp70-biased interactors (Figure 5B,
green circles).
We then compared the interaction profiles of different Hsp70
and Hsp90 isoforms. Virtually all eukaryotic genomes encode
multiple isoforms of both of these chaperones, even within the
same cellular compartment (Powers and Balch, 2013). However,
it is not known whether they have distinct client-protein prefer-
ences. The three cytoplasmic Hsp70 isoforms we profiled
(Hsp70, Hsc70, and Hsp70B0) had very similar interaction pro-
files across the 800 proteins we tested (Figures 5C and S4B).
Similarly, the interaction profiles for Hsp90a and Hsp90b corre-
lated strongly (R2 = 0.76; Figure 5D). A few cochaperones had
strong isoform preferences. BAG proteins interacted more
strongly with Hsp70B0 than with Hsp70 or Hsc70 (Figure S4B
and data not shown). The Hsp90 cochaperone UNC45A, but
not its homolog UNC45B, were previously described as an
Hsp90b-specific cochaperone (Chadli et al., 2008) and this
held true in our assay. We detected a similar preference for
FKBP38 (Figure 5D). We further validated the isoform preference
of UNC45A and FKBP38 by coimmunoprecipitation with the
endogenous Hsp90 isoforms (Figure S4A). These outliers pro-
vide an avenue for investigating distinctions in the functions of
specific chaperone isoforms. By and large, however, Hsp70
and Hsp90 isoforms interacted with the same clients and cocha-
perones, and did so with very similar affinities.
BAG2 and RPN1 Are Tightly Connected to the Hsp70
Machinery
Our AP-MS interaction network suggested unique roles for each
of the BAG proteins, except for BAG2 (Figure 3E). Illustrating the
power of combining unbiased AP-MS analysis with the quantita-
tive nature of the LUMIER assay, we uncovered a striking inter-
action pattern for BAG2. Across the 800 queried proteins,
BAG2 interactions were remarkably similar to those of Hsc70
(R2 = 0.77; Figure 5E). In contrast, the other BAG proteins had
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Figure 5. Clustering of Chaperones, Cocha-
perones, andQuality-Control Factors Based
on Similarities in Client Interaction Profiles
(A) Chaperones, cochaperones, and protein qual-
ity-control factors were clustered based on their
interaction profiles with 800 query proteins. Clus-
tering corresponds well to known biological com-
plexes. Three components of the 19S proteasome
(purple) cluster together, as do two prefoldin sub-
units (green). Hsp70 and its cofactors (yellow) and
BAG proteins (red) cluster separately from Hsp90
and its cochaperones (blue).
(B) Significant correlation between Hsc70 and
Hsp90 client interaction profiles. A total of 800
proteins (light blue) were assayed for interaction
with Hsc70 or Hsp90 by LUMIER. Hsp90 cocha-
perones (red) interact exclusively with Hsp90, and
Hsp70 cochaperones (ochre) interact exclusively
with Hsc70. Kinases (filled blue circles) generally
interact more strongly with Hsp90 than with
Hsc70, whereas p53 and HSF1 (green) prefer
Hsc70.
(C) The client interaction profiles of Hsp70 iso-
forms Hsc70 and Hsp70 are highly similar.
(D) The client interaction profiles of Hsp90 iso-
forms Hsp90a and Hsp90b are highly similar. Most
clients (blue) interact with Hsp90a and Hsp90b to a
similar degree. The cochaperones UNC45A and
FKBP38 (filled blue circles) interact more strongly
with Hsp90b. In contrast, the UNC45A paralog
UNC45B interacts with both isoforms to a similar
degree.
(E) The BAG2 interaction profile is almost identical
to that of Hsc70, suggesting that it is a general
cofactor for Hsp70 chaperones. In contrast, BAG3
(F) and BAG4 (G) are more specific, interacting
primarily with the small heat shock proteins Hsp22
and Hsp27 (BAG3) and the mRNA decapping
factor DCP1B (BAG4)
(H–J) Rpn1 (H) is a component of the proteasome
regulatory particle and its interaction profile cor-
relates significantly with that of Hsc70. In contrast,
Rpn10 (I) and Rpn13 (J), also components of the
core particle, mainly interact with other subunits of
the proteasome.
See also Figure S4.highly specific interactions that complemented our results from
AP-MS. BAG3 and BAG4 showed a strong association only
with the small heat shock protein Hsp27 (Figure 5F) and the
mRNA decapping complex member DCP1B, respectively (Fig-
ure 5G), whereas BAG1 interacted with several proteasome sub-
units (Figure S4C). Thus, BAG2 appears to be a general cofactor
for Hsp70with little client protein preference, whereas other BAG
proteins have unique clients.
The interaction profile of RPN1/PSMD2, a subunit of the pro-
teasome regulatory particle, was also highly correlated with
that of Hsc70 (R2 = 0.51; Figure 5H). RPN1 interacted strongly
with four BAG proteins and with the ubiquitin ligase CHIP. This
was in contrast to the three other subunits (RPN10, RPN13,
and RPT2) that primarily interacted with other proteasome sub-
units (Figures 5I, 5J, and S4E). Although all four subunits are
part of the base of the proteasome regulatory particle (Lander
et al., 2012), RPN1 clustered together with Hsp70 rather thanwith the other proteasome subunits (Figure 5A). RPN1 is thought
to act as a scaffold protein that binds and recruits diverse pro-
teasome-associated factors to the proteasome (Finley, 2009).
The correlation between the RPN1 and Hsc70 interaction pro-
files suggests that RPN1 could also serve as a bridge between
protein folding by the Hsp70 machinery and protein degradation
by the proteasome.
Another factor that correlated well with Hsc70 was the ubiqui-
tin ligase CHIP (Figure S4E). CHIP binds Hsp90 and Hsp70 with
similar affinities and can regulate the degradation of chaperone
clients (Kundrat and Regan, 2010). However, LUMIER revealed
an interaction profile that correlated with Hsc70 (R2 = 0.74)
even more strongly than with Hsp90b (R2 = 0.38; Figures S4F
and S4G). Indeed, hierarchical clustering placed it together
with Hsp70 proteins rather than with Hsp90 (Figure 5A). This
finding suggests that CHIP is most tightly coupled to the
Hsp70 chaperone machinery.Cell 158, 434–448, July 17, 2014 ª2014 Elsevier Inc. 441
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Figure 6. Quantitative View of the Human Protein-Folding Landscape
A total of 800 query proteins (arranged in columns) were assayed for interaction with 60 different chaperones, cochaperones, and quality-control factors (rows) by
a quantitative LUMIER assay. Query proteins were clustered based on their interaction profiles. Some of the biologically coherent clusters are highlighted in more
detail. Proteins that share the same fold or are part of the same biological complex in each cluster are indicated in color.
(A) LRR proteins (red) and Argonaute proteins (orange) form distinct clusters. LRR proteins interact strongly with SGT1, while Argonaute proteins associate with
PP5.
(B) The R2TP complex members (purple) form two separate clusters.
(C) Hsp90 cochaperone cluster.
(D) Kinases (orange) cluster together and interact specifically with CDC37, but not with CDC37L1.
(E) NUDCD1 associates with DEAH/DEAD box helicases (green).
(F) BAG proteins that cluster together interact strongly with Hsp70 proteins, Rpn1, Hsf1, and Hsf2.
(G) Kelch domain protein cluster (brown) with NUDCD3.
(H) Proteasome cluster.
(I) RCC1 repeat protein FBXO24 (purple) interacts with NUDCD2.
(J) G protein g subunits (green) interact with prefoldins.
See also Table S1.Quantitative Client Profiling Reveals Unique
Cochaperone Specificities
We next focused on the client specificity of chaperones and co-
chaperones, and clustered the 800 tested clients based on their
LUMIER interaction patterns. This analysis revealed several442 Cell 158, 434–448, July 17, 2014 ª2014 Elsevier Inc.client groups that shared specific chaperones or cochaperones
(Figure 6). For example, seven members of the cytoplasmic RNA
polymerase assembly complex R2TP interacted with the prefol-
din subunits PFDN2 and PFDN5. However, the R2TP subunits
formed two distinct clusters (Figure 6B). The four proteins in
the first cluster (PFDN2 itself, VBP1, UXT, and PDRG1) are all
prefoldin-like proteins and interacted primarily with PFDN2 and
PFDN5. The second cluster (URI1, POLR3A, and RPAP3) inter-
acted also with RPAP3 and Hsp90 in addition to the prefoldins
(Figure 6B). Yet another distinct prefoldin interaction module
consisted of G protein b subunits, linking prefoldins to G pro-
tein-coupled receptor (GPCR) signaling (Figure 6J). While prefol-
dins generally have been thought to participate primarily in the
folding of actin and tubulin (Lundin et al., 2010), our results
expand the specificity of this little-characterized chaperone
system.
Hierarchical clustering of the LUMIER data revealed several
additional cochaperone modules. Proteins with kinase domains
clustered together, as was expected from their known prefer-
ence for CDC37 (Figure 6D). Leucine-rich repeat (LRR) proteins
and Argonaute proteins also formed distinct clusters. LRR
proteins interacted particularly strongly with the SGT1 cochaper-
one, whereas Argonaute proteins bound the protein phospha-
tase PP5 and p23, both of which are well-characterized Hsp90
cochaperones (Figure 6A).
NUDC Family Cochaperones Associate with Distinct
b-Propeller Folds
Perhaps the most striking client specificity we uncovered by
LUMIER involved the NUDC family of cochaperones. The human
genome encodes four evolutionarily related proteins in this family
(Figure S5A). NUDC proteins have been found to associate with
the Hsp90 complex, but the biological roles of these cochaper-
ones are largely unknown (Zheng et al., 2011).
We noticed that three of the four NUDC proteins associated
with a group of proteins that had no functional relationship to
each other, yet contained structurally related folds. NUDC inter-
acted strongly with WD40 repeat proteins (Table S1). NUDCD3,
in contrast, interacted with proteins with Kelch domains (Fig-
ure 6G; Table S1). For NUDCD2, the most significant interacting
protein was FBXO24, an RCC1 repeat protein (Figure 6I). Since
WD40, Kelch, and RCC1 domains all have b-propeller folds,
we reasoned that NUDC proteins might represent a novel family
of b-propeller specific cochaperones.
To more rigorously test the specificity of NUDC proteins, we
cloned into our LUMIER vector 275 genes that contained a
predicted b-propeller domain. In addition, we cloned 156 genes
with LRRs, because several LRR proteins clustered together as
SGT1-interacting clients (Figure 6A). Finally, we included as
controls 80 kinases that were strong Hsp90 and Cdc37 clients
(Taipale et al., 2012). We quantitatively assayed the interaction
of these 511 proteins with SGT1, CDC37, and all four NUDC
family members (Figure 7A). Except for NUDCD1, each cocha-
perone showed a striking client preference. As expected,
CDC37 interacted virtually exclusively with kinases (p < 0.0001,
Mann-Whitney test; Figure 7A). Similarly, although SGT1 inter-
acted with some non-LRR proteins, it had significantly stronger
interactions with LRR proteins than with other domains (p <
0.0001). NUDC selectively associated with WD40 repeats,
NUDCD2 with RCC1 repeats, and NUDCD3 with Kelch domains
(p < 0.0001 for each; Figure 7A). Although there was additional
weak crosstalk between some of these cochaperones and their
clients, these specific associations stood out. We further vali-dated the specificity of NUDC and NUDCD3 with AP-MS.
Endogenous NUDC, but not NUDCD3, copurified with the
3xFLAG-tagged WD40 protein FBXW2, whereas endogenous
NUDCD3, but not NUDC, copurified with five different 3xFLAG-
tagged Kelch domain proteins in 293T cells (Figure S5B).
We then tested whether the cochaperone specifically bound
the kinase, b-propeller, or LRR domain by coimmunoprecipita-
tion (Figures 7B and S5A). As reported before (Taipale et al.,
2012), CDC37 interacted with the kinase domain of ARAF, and
SGT1 interacted with the LRR domain of FBXL2 (Figure 7B).
NUDC interacted with the WD40 domain of FBXW2, NUDCD2
interacted with the RCC1 domain of FBXO24, and NUDCD3
interacted with the Kelch domain of KLHL38 (Figure 7B). In
each case, the interaction with these isolated domains was as
strong as that with the full-length protein. These results establish
that the evolutionarily related NUDC cochaperones recognize a
specific b-propeller fold in their clients (Figure 7C).
NUDCD1was the onlymember of the NUDC family that did not
interact with b-propeller domain proteins in our query set. How-
ever, AP-MS and LUMIER revealed that it did interact strongly
with multiple DEAH/DEAD box RNA helicases and several sub-
units of the COPI complex, which regulates retrograde signaling
between Golgi compartments (Figures 2 and 6E). Although two
members of the COPI complex (COP-a and COP-g2) contain
b-propeller domains, we could not detect an interaction between
these subunits and NUDCD1 (data not shown). Interestingly,
however, in contrast to other NUDC proteins, NUDCD1 itself
contains a b-propeller domain (Figures 7C and S5A), which
also connects this cochaperone to b-propeller domains.
Cochaperones May Facilitate the Evolutionary
Diversification of Protein Folds
Wenext askedwhether theemergenceof fold-specificcochaper-
ones might have enabled the diversification of their client protein
folds during evolution. Chaperones with broad client specificities
can promote evolution by providing a buffering mechanism
against destabilizing mutations (Jarosz et al., 2010; Tokuriki and
Tawfik, 2009). Domain-specific cochaperones might facilitate
evolution in a similar but domain-specific manner. We therefore
analyzed the genomes of 147 fully sequenced organisms. We
calculated the number of proteins with cochaperone-specific
protein folds (LRR, WD40, Kelch, and RCC1) and asked whether
the number of such proteins was larger in genomes that contain
the specific cochaperone compared with those without the
cochaperone (after controlling for nonspecific expansion of the
proteome). Genomes that contained the NUDCD3 or SGT1 co-
chaperones showed a striking and highly significant enrichment
for their client folds (Kelch and LRR, respectively; Figures 7D
and 7E). The associations of NUDC and NUDCD2 with their
cognate client folds were not statistically significant (data not
shown). These results suggest that the evolution and diversifica-
tion of LRRdomains andKelch repeatsmay have been promoted
by the emergence of cochaperones specific to these folds.
DISCUSSION
We have systematically and quantitatively characterized the
chaperone-cochaperone-client interactome in human cells.Cell 158, 434–448, July 17, 2014 ª2014 Elsevier Inc. 443
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Figure 7. NUDC Family Proteins Are Specific Cochaperones for b-Propeller Domains
(A) NUDC family cochaperones, SGT1, and CDC37were assayedwith a quantitative LUMIER assay for interaction with 80 kinases, 156 LRR domain proteins, and
275 proteins with a b-propeller domain. Bait proteins are organized by domain (annotated below) and rank sorted based on their interaction with a specific
cochaperone (kinases with CDC37, LRRs with SGT1, WD40 with NUDC, RCC1 with NUDCD2, and Kelch with NUDCD3).
(B) Cochaperones recognize specific domains in their clients. The indicated full-length proteins or truncated constructs were tagged with a 3xFLAG epitope and
transfected into 293T cells. Their interaction with endogenous Hsp90 (top panel) or with endogenous, specific cochaperone (middle panel) was assayed by
coimmunoprecipitation. For NUDCD2, a 3xHA-tagged construct was cotransfected with FBXO24 and the blot was probed with an anti-HA antibody.
(C) Evolution of the NUDCprotein family members and their client specificity. NUDC, NUDCD2, and NUDCD3 each recognize distinct b-propeller folds. NUDCD1,
in contrast, associates with proteins with an unrelated fold (RNA helicases and the COPI complex), but itself contains a b-propeller domain. The COPI complex
image is used with permission from Science Magazine.
(legend continued on next page)
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The broad and quantitative nature of our approach allowed the
analysis of protein-protein interaction data by hierarchical clus-
tering, illuminating unexpected and highly specific connections
between chaperones and particular biological processes. We
validated many interactions by orthogonal interaction assays
and functional assays, but, as in any endeavor of this size, a large
fraction of the network remains unexplored. Here, we highlight
only the most salient insights revealed by our analysis, to
encourage others to explore this resource in their own
investigations.
Cochaperones and Protein Complex Assembly
Systematic studies of the components of the proteostasis net-
works have almost exclusively focused on chaperones rather
than their cofactors. Our data suggest surprisingly diverse roles
for cochaperones in particular cellular processes, including spin-
dle assembly (BAG5 and MAD proteins), DNA replication
(FKBP51 and the MCM complex), mRNA decapping (BAG4
and P bodies), and GPCR signaling (prefoldins and G protein b
subunits). These cellular processes are completely unrelated,
yet conceptually they share key features. The cochaperone
interactors are individual components of much larger multipro-
tein complexes, and in each case these complexes must be
assembled in a specific location at a specific time. Further, their
assembly is often regulated by dramatic conformational changes
in the associated proteins.
Our results suggest that cochaperones are broadly involved in
the assembly of multiprotein complexes. On the one hand, co-
chaperones provide a means of recruiting the Hsp90 or the
Hsp70 chaperone system to very specific biological processes.
In contrast to Hsp70, which generally recognizes unfolded pro-
teins with exposed hydrophobic stretches, cochaperones asso-
ciate with proteins that have specific domains. Presumably, they
associate with domains that are at least transiently recognizable
yet retain a level of conformational flexibility that guides them to
the chaperone machinery. Recruitment of Hsp70 by these co-
chaperones would thus create a local pool of the chaperone to
facilitate transitions between conformational states. On the
other hand, certain cochaperone interactions are independent
of the core chaperones (e.g., FKBP51 and the MCM complex)
and likely serve specific roles that do not require extensive
structural rearrangements driven by chaperones. It will be of
great interest to determine whether those functions evolved
from the initial chaperone interaction or vice versa.
Domain-Specific Cochaperones, Client Protein
Recognition, and Protein Fold Evolution
Our analysis revealed that in addition to the well-known kinase
specificity of CDC37, other cochaperones also have distinct
specificities. SGT1 interacts particularly strongly with clients(D) Genomes that encode the Kelch-domain specific cochaperone NUDCD3 co
NUDCD3. The number of Kelch domains was analyzed in each of 147 fully sequen
of total number of proteins) was compared between species that have the NUDCD
for 10,000 random eukaryotic proteins that were assayed for similar evolutionary
NUDCD3 and black lines show the t-statistic for three other cochaperones that a
(E) Evolutionary analysis of LRR domain evolution with LRR-specific cochaperon
See also Figure S5 and Table S1.with LRRs. (This was suggested previously [Kadota et al.,
2010], but awaited systematic testing.) We also uncovered
previously unsuspected specificities for the poorly characterized
NUDC family cochaperones. These evolutionarily related
cochaperones recognized distinct but structurally homologous
b-propeller domains (Figure 7C). The interaction patterns of all
of the domain-specific cochaperones were analogous to that
of CDC37. That is, although the cochaperones clearly preferred
a specific protein fold, neither they nor Hsp90 associated with all
members of that family. Furthermore, the clients did not phyloge-
netically cluster, but were scattered throughout the evolutionary
tree (Figure S5C). When they did interact, the strength of the
interactions varied over a broad continuum (Figure S5C). Thus,
these results point to a dynamic process of evolutionary diversi-
fication that is still at work.
In addition to their specific cochaperones, many b-propeller
proteins interacted with Hsp90, Hsp70, and prefoldins. WD40
domain proteins have also been shown to associate with the
TRiC/CCT chaperonin (Yam et al., 2008). Why might b-propeller
domains require somany chaperones and a dedicated system of
cochaperones? The canonical b-propeller structure provides a
clue. b-propellers are composed of repeating units of four anti-
parallel b-sheets arranged around a ring. b-sheets from the last
repeat are often circularly permuted to the first repeat, closing
the ring. We suggest that these proteins have a particularly
high requirement for chaperone proteins to keep the b-propeller
soluble before ring closure occurs.
b-propellers from different families share very little sequence
homology, and therefore it has been difficult to resolve whether
they evolved from a common ancestral fold or the fold is an
example of convergent evolution (Chaudhuri et al., 2008; Hudson
and Cooley, 2008). Our results suggest that common ancestry is
the more parsimonious scenario. That is, the evolution of b-pro-
peller folds by duplication and diversification was facilitated by
the evolutionary expansion of the NUDC family. This seems
more plausible than the alternative scenario, where unrelated
repeats happened to converge on the same fold while requiring
highly related NUDC chaperones.
Our evolutionary analysis revealed that Kelch and LRR do-
mains coevolved with their cochaperones NUDCD3 and SGT1,
respectively. Eukaryotic proteomes with these cochaperones
contain a larger fraction of their respective client protein folds
compared with proteomes without them. Although it is possible
that these cochaperones evolved as a response to an expanded
repertoire of client protein folds, we consider it more likely that
the emergence of NUDCD3 and SGT1 promoted the divergence
of the clients. The finding that chaperones can buffer genetic
variation in several model organisms and in experimental evolu-
tion supports this interpretation (Jarosz et al., 2010; Tokuriki and
Tawfik, 2009).ntain significantly more proteins with Kelch domains than genomes without
ced eukaryotic proteomes. Normalized Kelch domain abundance (as a fraction
3 ortholog and those that do not. Histograms display the t-statistic distribution
co-occurrence with Kelch domains. The orange line shows the t-statistic for
re not Kelch specific.
e SGT1, performed as in (D).
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Concluding Remarks
The architecture of the chaperone-cochaperone-client interac-
tion network reported here has broad implications for human
biology and medicine. A large number of human diseases,
ranging from cystic fibrosis to cancer and neurodegeneration,
are now known to ultimately stem from problems in the folding
of specific proteins. However, these proteins do not misfold in
isolation. Rather, their misfolding ramifies at a system-wide level
to impinge on critical cellular functions (Powers et al., 2009),
derailing the homeostatic control of protein folding, trafficking,
and degradation in a tissue-specific manner. The interaction
network we have uncovered provides a robust framework for
systematically dissecting the effects of such perturbations and
characterizing the unique features of the network in different
tissues and cellular states.
In addition, these interactions can be exploited to study
drug-target interactions in living cells (Taipale et al., 2013).
Here, we further expanded this approach to another cochaper-
one, FKBP36. It is very likely that many chaperone-client inter-
actions will prove amenable to such an analysis. Furthermore,
given that the approach relies on fundamental biophysical prin-
ciples rather than a specific functional readout, it should be
generally applicable to proteins that traditionally have been
difficult to assay for small-molecule binding. Thus, our results
provide not only a springboard for deciphering how the protein
homeostasis network is dynamically rewired in various disease
states, but also a platform for evaluating the therapeutic
potential of small molecules that could ameliorate such
perturbations.
EXPERIMENTAL PROCEDURES
Clones and Cell Lines
All clones originated from the human ORFeome collection 7.1 or were cloned
from cDNA by PCR. Clones were transferred into a mammalian expression
vector with a 3xFLAG-V5 epitope tag or a pLenti6-based lentiviral vector
containing a 3xFLAG-V5 epitope tag or Renilla luciferase protein. Stable poly-
clonal 293T cell lines were established by lentiviral infection, and expression of
each protein was verified by western blotting or luciferase assay. Mutant con-
structs were created by site-directedmutagenesis. All clones used in the study
were validated by sequencing or by restriction digestion.
LUMIER Assay
LUMIER assay was performed as previously described (Taipale et al., 2012)
with one modification. Instead of calculating the prey/bait (luminescence/
ELISA) ratio, we used normalized luminescence Z scores as a quantitative
interaction measure. ELISA values were used to remove bait proteins that
were not detectably expressed in the assay (see Extended Experimental
Procedures for details).
AP-MS
AP-MS was performed as previously described (Kean et al., 2012) except that
sodiummolybdate was included in the lysis buffer to help preserve chaperone-
client interactions. Samples were analyzed on an AB SCIEX 5600 TripleTOF
system by data-dependent acquisition (DDA). See Extended Experimental
Procedures for details and for AP-MS data analysis.
Hierarchical Clustering
Cochaperones and client proteins were organized by hierarchical clustering
with average linkage and centered Pearson correlation. Only bait proteins
that were detectably expressed (as measured by ELISA) in at least 50 of the
60 experiments were included in the analysis.446 Cell 158, 434–448, July 17, 2014 ª2014 Elsevier Inc.Data Sets
All data sets can be accessed online at http://prohits-web.lunenfeld.ca. All in-
teractions have also been submitted to BioGRID and the IMEx consortium
(www.imexconsortium.org) through IntAct (Orchard et al., 2014) and assigned
the identifier IM-22301.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and one table and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2014.05.039.
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